Publications

Value Health.

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

26-01-2023

Key

J Mol Diagn.

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

25-01-2023

Key

N Engl J Med

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

08-12-2022

Key

Clinical drug investigation

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

09-07-2025

Annals of oncology : official journal of the European Society for Medical Oncology

Health-Related Quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared to ipilimumab in a randomized phase 3 trial.

18-06-2025

International journal of cancer

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

02-06-2025

ESMO open

Financial toxicity and socioeconomic impact of cancer in Europe.

01-06-2025

PharmacoEconomics - open

Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.

01-05-2025

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer.

01-05-2025

PharmacoEconomics

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.

01-05-2025

The Lancet. Oncology

Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer.

01-05-2025

Journal of cancer survivorship : research and practice

"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care.

01-02-2025

Future oncology (London, England)

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

01-12-2024

BMC cancer

Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives.

22-11-2024

Molecular oncology

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

01-11-2024

Breast (Edinburgh, Scotland)

DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS.

01-10-2024

Critical reviews in oncology/hematology

Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review.

01-10-2024

Acta oncologica (Stockholm, Sweden)

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers.

10-09-2024

Therapeutic advances in medical oncology

Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.

23-08-2024

Gynecologic oncology

Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective.

01-08-2024

European journal of cancer (Oxford, England : 1990)

EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe.

01-08-2024

Scientific reports

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.

16-05-2024

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Organization of head and neck cancer rehabilitation care: a national survey among healthcare professionals in Dutch head and neck cancer centers.

01-05-2024

JMIR research protocols

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.

18-04-2024

The Lancet. Oncology

The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.

01-04-2024

Journal for immunotherapy of cancer

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

26-03-2024

International journal of cancer

Differences in time to patient access to innovative cancer medicines in six European countries.

01-03-2024

PharmacoEconomics - open

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis.

01-01-2024

Gynecologic oncology reports

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer.

01-12-2023

BMC cancer

Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.

14-11-2023

European journal of cancer (Oxford, England : 1990)

Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.

01-10-2023

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Health-state utilities in long-term advanced melanoma survivors comparable with the general population.

01-09-2023

Drug discovery today

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

01-08-2023

European journal of cancer (Oxford, England : 1990)

Duty to recontact in genomic cancer care: A tool helping to assess the professional's responsibility.

01-06-2023

Radiology

Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.

01-04-2023

Frontiers in oncology

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

28-03-2023

BMJ open

EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.

07-03-2023

BMC cancer

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.

07-01-2023

The Journal of molecular diagnostics : JMD

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

01-01-2023

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.

01-01-2023

The New England journal of medicine

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

08-12-2022

European journal of cancer (Oxford, England : 1990)

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

01-11-2022

Gynecologic oncology

Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.

01-06-2022

Scientific reports

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes.

10-05-2022

BMC cancer

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

06-05-2022

Cancers

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

31-03-2022

BMC medical research methodology

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.

27-03-2022

International journal of health policy and management

Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.

01-03-2022

Nederlands tijdschrift voor geneeskunde

[Clinical efficiency research with expensive drugs: doing more with less investment].

15-02-2022

Cancer discovery

Improving the Affordability of Anticancer Medicines Demands Evidence-Based Policy Solutions.

01-02-2022